NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AI Proteins

AI Proteins

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.aiproteins.com/

Last Round

Series A

Nov 19, 2025

Total Funding Raised

$59.7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AI Proteins is a biotechnology company that utilizes an artificial intelligence-based design and a high-throughput drug discovery platform to create synthetic miniproteins for a variety of therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

de novo protein designgenerative AIcomputational drug discoveryprotein therapeuticsAI drug discoverysynthetic proteinsundruggable targetsbiotech platformdrug developmentin silico drug designprotein engineeringAI biotechtherapeutic discoverydrug discovery pipelinepharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AI Proteins Comparables

Compare AI Proteins with similar companies based on industry and business-model similarity.

AI Proteins comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nabla Bio
89%
Evozyne
88%
Profluent Bio
86%

AI Proteins Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 19, 2025
SeedNov 3, 2022

Key People

Founding team and executive leadership

Chris Bahl

Chief Executive Officer, President, Founder, Chief Scientific Officer, Member Board of Directors

Founding Team

AI Proteins Investors

Notable investors and investment history

AI Proteins investors
InvestorRounds
Santé VenturesSeries A
Mission BioCapitalSeries A
Santé VenturesSeries A
Cobro VenturesSeries A, Seed
Tachyon VenturesSeed
LightChain CapitalSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 78% MoM, reaching 7.7K.

  • Nov 19, 2025

    $42M round led by Mission BioCapital and Santé Ventures.

AI Proteins Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AI Proteins Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AI Proteins's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range41
Year Founded2021
Last FundingNov 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.